The mouse liver tumorigenic conazole fungicides triadimefon and propiconazole have previously been shown to be in vivo mouse liver mutagens in the Big Blueä transgenic mutation assay when administered in feed at tumorigenic doses, whereas the nontumorigenic conazole myclobutanil was not mutagenic. DNA sequencing of the mutants recovered from each treatment group as well as from animals receiving control diet revealed that propiconazoleand triadimefon-induced mutations do not represent general clonal expansion of background mutations, and support the hypothesis that they arise from the accumulation of endogenous reactive metabolic intermediates within the liver in vivo. We therefore measured the spectra of endogenous DNA adducts in the livers of mice from these studies to determine if there were quantitative or qualitative differences between mice receiving tumorigenic or nontumorigenic conazoles compared to concurrent control animals. We resolved and quantitated 16 individual adduct spots by 32 P postlabelling and thin layer chromatography using three solvent systems. Qualitatively, we observed the same DNA adducts in control mice as in mice receiving conazoles. However, the 13 adducts with the highest chromatographic mobility were, as a group, present at significantly higher amounts in the livers of mice treated with propiconazole and triadimefon than in their concurrent controls, whereas this same group of DNA adducts in the myclobutanil-treated mice was not different from controls. This same group of endogenous adducts were significantly correlated with mutant frequency across all treatment groups (P 5 0.002), as were total endogenous DNA adduct levels (P 5 0.005). We hypothesise that this treatment-related increase in endogenous DNA adducts, together with concomitant increases in cell proliferation previously reported to be induced by conazoles, explain the observed increased in vivo mutation frequencies previously reported to be induced by treatment with propiconazole and triadimefon.
Introduction
Transgenic rodent in vivo mutation assays have been designed to assess the ability of a chemical to induce promutagenic damage in the DNA of tissues and for this damage to be converted into alterations in the primary structure of the DNA detectable as phenotypic mutants in a recoverable transgene. These assays have proven to be useful in confirming the linkages between tissue-specific DNA adducts, mutations and tumorigenesis for a variety of genotoxic carcinogens (1) (2) (3) . However, several studies of compounds that are generally inactive in short-term genotoxicity assays have found that these chemicals also paradoxically increase mutant frequencies in transgenic rodents (4) (5) (6) .
Conazoles are used in both pharmaceutical and agricultural settings as antifungal agents. Some conazoles, such as propiconazole and triadimefon, induce liver toxicity and hepatocellular tumours in mice (7) (8) (9) (10) when administered chronically in feed. Other conazoles, such as myclobutanil, do not induce liver tumours in mice (11, 12) . All of these chemicals are generally not active in short-term genotoxicity tests, suggesting that these conazoles and their direct metabolites are not DNA-reactive, per se. However, we have previously reported that administration of the two tumorigenic conazoles, propiconazole and triadimefon, induces significant increases in lacI reporter gene mutant frequencies in the livers of Big Blueä transgenic mice (13) . The spectra of mutants induced by these conazoles were different from those recovered from untreated controls and from animals receiving the nontumorigenic conazole myclobutanil (14) . To reconcile the observed in vivo mutagenicity of the tumorigenic conazoles with their inactivity in short-term genotoxicity assays, we hypothesised that disregulation of cellular metabolism by the conazoles led to an accumulation of electrophilic metabolic intermediates in the liver in vivo, which are capable of inducing promutagenic DNA damage.
Several previous studies have demonstrated that administration of tumorigenic conazoles induces increased oxidative stress in mouse liver (15) (16) (17) . Apex1 [DNA-(apurinic or apyrimidinic site) lyase], which is a reactive oxygen species (ROS)-responsive regulator of DNA damage response genes and an endonuclease responsible for base excision repair of abasic sites, was upregulated 1.5-fold. H2afx (H2A histone family, member X) was upregulated 2.3-fold, and is involved in recruitment of repair proteins to sites of DNA damage in chromatin. Hepatic expression of Akr1b7, associated with detoxification of lipid peroxidation products produced by reactive oxygen species, was elevated by 2500 ppm propiconazole administration, as was DNA damage response genes Gadd45a and Gadd45b, which are upregulated by DNA damage and are involved in cell cycle control, DNA repair and apoptosis. Bruno et al. (18) found that propiconazole administration significantly increased hepatic protein carbonylation, indicating increased oxidative damage in the liver, as well as decreased GSH levels and increased GST activity. In a comparative analysis of transcriptional and proteomic changes induced by propiconazole in mouse liver, Ortiz et al. (19) demonstrated that expression of oxidative stress response genes was up-regulated, including multiple glutathione-S-transferases. Recently, Nesnow et al. (20) demonstrated that propiconazole-induced oxidative stress in both mouse liver in vivo and in cultured mouse hepatic cells in vitro via a cytochrome P450-mediated mechanism, and suggested that the hydroxyl radical was a major form of ROS produced.
A variety of endogenous reactive electrophiles are formed as a consequence of normal cellular metabolism, many of which are capable of reacting with DNA to form covalent DNA adducts.
32 P-postlabelling techniques have been developed that allow for the separation and quantitation of many of these endogenous DNA adducts (21, 22) . This approach has been used to study the impacts of chemical and dietary exposures on the levels of these adducts (23) (24) (25) (26) (27) (28) . Levels of these endogenous adducts are significantly elevated in the progression of cervical cancer, with higher levels present in inflammation, dysplasia and cancer relative to normal tissue (22) . In the present study, we have employed a modification of this approach to resolve and quantitate this endogenous DNA damage into 16 individual adduct spots. We have applied this technique to resolve and quantitate the spectrum of endogenous DNA adducts present in liver tissues of conazole-treated animals from the same studies for which we previously reported in vivo mutant frequencies (13, 14) .
Materials and methods

DNA adduct analysis
Animal treatments and analysis of mutants have been previously described (13, 14) . Briefly, male C57BL/6 Big BlueÒ mice were obtained from Stratagene (La Jolla, CA). Triadimefon administered in feed at 1800 ppm and a concurrent control group were analysed in one study (Study 1), while propiconazole (2500 ppm in feed) and myclobutanil (2000 ppm in feed), together with a separate concurrent control group, were analysed at a later time in a second study (Study 2). These doses and route of administration reflect those in the reported mouse liver tumorigenicity studies to increase triadimefon-and propiconazole-induced increased tumour incidence, and a maximum tolerated dose for the nontumorigenic myclobutanil, as described in Allen et al. (29) .
Animals received the treated feed for 4 days, ad libitum, after which animals were immediately euthanised by carbon dioxide asphyxiation and cervical dislocation. Livers were removed, flash frozen in liquid nitrogen and stored at À80°C until analysis. Each treatment group contained nine animals, although only six animals from each group were analysed for mutation induction. The DNA adduct analyses reported in this manuscript were performed on tissues from all nine animals from these same studies. Comparisons of adducts with mutation outcomes included data from only those animals where data for both endpoints were available (n 5 6).
DNA was isolated from liver tissue of individual animals using the salt and spermine method (30) . DNA adduct analysis was conducted using 32 P postlabelling with nuclease P1 enhancement essentially as described previously (31) . Briefly, DNA (5 lg/assay) was hydrolysed to 3#-mononcleotides by digestion with micrococcal nuclease (Sigma-Aldrich, St Louis, MO) and spleen posphodiesterase (Sigma-Aldrich). Adducts were pre-enriched by digestion with nuclease P1 (Sigma-Aldrich) and then labelled at the 5# position with 3#-phosphotase-free polynucleotide kinase (Roche Diagnostics, Indianapolis, IN) and c-32 P-labelled ATP (Perkin Elmer, Waltham, MA) at pH 7.5. Resolution of radiolabelled adduct nucleotides was carried out by anion-exchange thin layer chromatography (TLC) on 10 Â 20 cm polyethyleneimine (PEI) cellulose plates (Macherey-Nagel 801 063, batch 01.07, Easton, PA). The TLC conditions used to detect endogenous DNA adducts was completed with modified solvent systems based on previously described systems (22) . DNA adduct resolution varies between batches of PEI cellulose plates. TLC solvent systems must be optimised for each batch of TLC plates to ensure complete adduct resolution. Direction 1 (D1) consists of 1.5 M formic acid containing varying concentrations of sodium phosphate as follows: (i) 75 mM sodium phosphate, (ii) 150 mM sodium phosphate and (iii) 225 mM sodium phosphate. D1 solvents were eluted from bottom to top overnight onto a 6-cm wick of 17 Chr Whatman chromatography filter paper, followed by a wash with H 2 O. Direction 2 (1:1 isopropanol:4 N ammonium hydroxide) was eluted left to right with no wick, followed by a wash with H 2 O. Normal nucleotides in each sample were quantitated in aliquots of the DNA digests removed prior to adduct enrichment by Nuclease P1, 32 P-labelled in parallel with adducts and resolved by one-directional PEI cellulose TLC (4.75 M ammonium formate, pH 5 3.5). Phosphor imaging of DNA adducts and normal nucleotides was performed using a Typhoon 9410 variable mode imager (GE Healthcare). DNA adducts levels were quantitated as previously described (32) . Briefly, serial dilutions of 32 P-ATP were spotted onto TLC plate strips and exposed together with the TLC plates to the phosphor storage screens. Following scanning of the screens, pixel volumes for each adduct spot and each of the diluted 32 P-ATP spots were calculated. The 32 P spots were cut out of the TLC plate strips and the radioactivity in each measured by liquid scintillation counting using 15 ml of Opti-Fluor scintillation cocktail (Perkin-Elmer, Waltham, MA). A standard curve for each exposure was then calculated to relate pixel volumes to counts per minute (cpm) from these standards, and then used to convert pixel volumes for the unknown adduct spots to cpm. Adduct levels were calculated as relative adduct labelling compared to the normal nucleotides measured in aliquots of each sample, as described, and reported as amol adducts/lg DNA.
Multiple TLC solvent systems were employed to detect possible stable DNA adducts. The first a TLC system previously used to resolve DNA adducts induced by polycyclic aromatic hydrocarbons was completed as described (31, 32) and with additional modifications. TLC was completed with 20 Â 20 cm plates with 3-cm 3MM Chr Whatman chromatography filter paper wicks in the D3 and D4 directions as well as with the previously described 10 Â 10 cm plates. The second system employed was previously used to detect stable penconazole DNA adducts in yeast (33) using the TLC conditions described for the resolution of covalent ochratoxin A DNA adducts (34) . The TLC was completed as described with 10 Â 10 cm TLC plates to attempt to detect stable conazole adducts in the mouse liver DNA from the current study. In addition, the system was modified to increase resolution by utilising 20 Â 20 cm plates with 3-cm 3MM Chr chromatography filter paper wicks in directions not already employing wicks. Finally, TLC conditions previously used to resolve stable DNA adducts in calf thymus DNA exposed in vitro to the pesticide alachlor (35) were also employed in the current study. No additional modifications were used with this TLC system.
Statistical analyses
Statistical analyses were performed using SAS v.9.2 software. Analysis of variance (ANOVA) was used to examine differences among treatment groups in adduct levels. The Shapiro-Wilk test and Levene's test were used to check the normality and homogeneity of variance assumptions of the ANOVA procedure. A log transformation (base 10) was used to improve distributional properties where needed. Means and standard errors of the means were calculated from nontransformed data, as were rank-order Spearman correlations. Differences between the control groups of the two studies and between treated and control groups within studies were tested with one-way analyses of variance (for more than two groups) or equivalently with t-tests for two groups. Pairwise differences between the conazole groups were calculated within twoway analyses of variance to adjust for study differences before testing for treatment differences. No adjustments for multiple comparisons were made to the ANOVA P-values; however, the R (v.2.12.2) package Q value was used to estimate the false discovery rate from groups of tests.
Results
There has been one published report of covalent DNA adducts formed as a result of exposure to a conazole fungicide, penconazole, in yeast cells (33) . Although we did not expect that direct conazole metabolite DNA adducts would be likely to be formed by the conazoles in this study, based on the known metabolism of these chemicals, we nonetheless utilised a variety of TLC systems to identify any such adducts that might be formed. Despite employing a variety of chromatographic conditions capable of resolving adducts spanning a wide range of polarity, no treatment-related conazole-DNA adducts were detected in any of the exposure groups.
Endogenous DNA adducts were analysed using three TLC solvent systems. Using this approach, we were capable of resolving groups of endogenous DNA adducts present in mouse liver DNA (Figure 1 ). Solvent System A resolved the most polar DNA adducts into 13 spots. Solvent System B washes the adducts resolved in Solvent System A off the plate, and resolves a less polar adduct spot, Adduct 14. Solvent System C elutes Adduct 14 off the plate and resolves an additional two adduct spots of even lower polarity. The endogenous DNA adduct patterns were qualitatively the same in treated and untreated mice in each of the three TLC solvent systems, indicating that exposure to the conazoles studied did not induce any novel DNA adducts detectable by this method (Figure 2) . In all samples, regardless of treatment group, the two least polar adducts (adducts 15 and 16, Solvent System C) were the most abundant, together accounting for about 90% of the total endogenous adducts detected. We did not observe any significant treatment-related effects in the levels of these two adducts by ANOVA. Similarly, the levels of Adduct 14 (Solvent System B) were not significantly changed from corresponding control samples in any treatment group.
In Study 1, adducts 1, 2, 3, 4, 5, 8, 12 and 13 were all significantly elevated (P , 0.05) in triadimefon-treated mice compared to the concurrent control animals ( Table I ). The total of all the Solvent System A adducts was also significantly elevated in the triadimefon-treated group. In Study 2, adducts 2, 3, 5 and 10 were significantly elevated in the propiconazoletreated animals compared to concurrent controls, while in the myclobutanil-treated group, only Adduct 8 was significantly elevated compared to control (Table I) .
Because a subset of the animals analysed for DNA adducts have previously been assessed for mutations (13, 14) , we were able to directly assess the correlations between endogenous DNA adduct levels and mutagenesis. Using a Spearman rank correlation to examine the association of mutant frequencies with endogenous adduct levels across all treatment groups, we found positive correlations for all adducts except Adduct 7, which had a nonsignificant negative correlation coefficient (Table II) . We observed that each of the endogenous DNA adducts except adducts 4, 7, 9, 10, 11, 14 and 15 were significantly correlated with mutant frequency (P , 0.05), as were the total adduct levels for Solvent System A and for Solvent System C, and also the sum of all endogenous adducts (Table II) .
We were also able to identify correlations between specific endogenous DNA adduct levels and relative dinucleotide mutabilities that we previously reported (14) . Relative dinucleotide mutability is a measure of the likelihood of a mutation occurring at each of the 16 possible dinucleotide sequences in the target gene, normalised to the prevalence of the dinucleotide in the sequence (36) . We observed significant positive correlations between subsets of endogenous DNA adducts and the relative mutabilities of specific dinucleotides (Table III) . Adduct 1 correlated only with mutability at CpT dinucleotides (Spearman R 5 0.975, P 5 0.005). The only other adduct that was correlated with CpT mutability was Adduct 8 (R 5 0.975, P 5 0.005), which was also highly correlated with GpC mutability (R 5 0.900, P 5 0.037). Adduct 4 showed significant correlation with only GpC mutability (R 5 0.900, P 5 0.037). Adduct 9 was significantly correlated only with the mutabilities of ApA (R 5 0.949, P 5 0.014) and ApC (R 5 0.975, P 5 0.005), which were not significantly correlated with any other endogenous adduct spots. Adducts 2, 3, 5, 6 and 12 all showed identical patterns of significant correlations with the relative mutabilities of GpG, GpC, GpT, CpA, CpG, TpC and TpT. Total Solvent System A adducts were also significantly positively correlated with this same group of relative dinucleotide mutabilities. No significant correlations were found between any of the endogenous DNA adducts and the relative mutabilities of ApG, ApT, CpC, TpA or TpG.
We also compared the adduct patterns in the two independent control groups in our studies. The total Group A adducts were somewhat lower in the control of Study 2 than in the Study 1 control group (P 5 0.09), with three of the adducts, adducts 5, 6 and 8, significantly lower in Control 2 (P , 0.01). 
Conazoles modulate endogenous DNA adducts Discussion
Relationship between endogenous DNA adduct levels and mutant frequencies In the present study, we find that specific subsets of endogenous DNA adduct levels are significantly elevated in the livers of mice receiving the tumorigenic conazoles triadimefon and propiconazole, compared to concurrent untreated controls or mice receiving the nontumorigenic conazole myclobutanil (Table I) . Further, we find significant positive correlations between our previously reported lacI mutant frequencies (13) and total Solvent System A endogenous adducts (Spearman R 5 0.536, P 5 0.002, Figure 3B ) and also between lacI mutant frequencies and total endogenous DNA adducts (R 5 0.500, P 5 0.005, Figure 3A) when assessed across all treatment groups. Nine out of the 16 individual adducts quantitated show a significant positive correlation with mutant frequency (Table II) . This is consistent with the hypothesis that a subset of the endogenous DNA adducts present in each cell is a major contributor to the formation of 'spontaneous' mutations, i.e. mutations observed in the absence of known exogenous exposure to mutagens.
This observed correlation between levels of endogenous DNA adducts and spontaneous mutation induction suggests a basis for understanding why the control group mutant frequencies were higher in the initial study conducted on triadimefon than in the later study conducted on myclobutanil and propiconazole (13) . The two studies were actually conducted about 18 months apart in two different facilities, and the animals used in each study were reared in two different barrier facilities. While the control mutant frequency in Study 2 was within the range of literature values reported for liver in this model (1), it was lower than we had previously observed in our laboratory (2, 3, 37) . We ruled out decreased sensitivity for detecting very pale blue lacIÀ mutant phenotypes as a possible explanation for lower control mutant frequencies by including appropriate k phage colour control plates with each packaging and plating. In light of the finding that mutant frequency is highly correlated with endogenous DNA adducts (Figure 3) , we hypothesise that the somewhat lower endogenous DNA adduct levels in the control animals in the second study compared to the control animals in the first study may provide a partial explanation for the lower observed mutant frequency in the second control group. Similarly, the endogenous DNA adduct levels in the myclobutanil-treated group were also low, again consistent with the observed low mutant frequency for this group. We hypothesise that differences in environmental factors during the rearing of the different groups of experimental mice contributed to lower endogenous adduct levels observed in Study 2. It has been demonstrated that dietary factors can influence the levels of bulky endogenous 
DNA adducts (38) as well as polar endogenous adducts in vivo (23-25).
Relationship between endogenous DNA adduct levels and relative dinucleotide mutability Many studies have shown that the induction of specific mutations by exogenous DNA adducts is dictated to a large extent by the molecular structure of the DNA adducts (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) as well as local sequence context (50) (51) (52) (53) (54) (55) . The molecular structure of each species of endogenous DNA adduct should similarly dictate the types of mutations that each induces. We examined the relationships between endogenous DNA adduct levels and the relative dinucleotide mutabilities previously reported (14) and found that specific endogenous DNA adducts were significantly correlated with specific dinucleotide mutabilities (Table III) . Several endogenous DNA adducts were significantly correlated with mutability of multiple dinucleotides. Adducts 2, 3, 5, 6 and 12 all showed the same pattern of significant correlation with mutability of GpG, GpC, GpT, CpA, CpG, TpC and TpT dinucleotides. One explanation for this shared pattern of correlation could be that each of these adducts are induced by a common upstream molecular precursor. For example, malondialdehyde, which can be formed metabolically as a product of lipid peroxidation or from the biosynthesis of prostaglandins can form DNA adducts with deoxyguanosine, deoxyadenosine and deoxycytidine (56) . So any alteration in cellular metabolism that induced higher levels of malondialdehyde might be expected to yield increases in all three of the corresponding DNA adducts and also to be correlated with increased mutabilities of dinucleotides containing these adducts. Adduct 9 correlates significantly only with mutability of ApA and ApC dinucleotides, which are not correlated with any other DNA adducts. Similarly, Adduct 8 correlates significantly only with mutability of GpC and CpT. Adduct 1 correlates only with CpT mutability, and Adduct 16 correlates only with GpT mutability. Only Adduct 11 fails to show a significant correlation with mutability of any dinucleotide, suggesting that it is not a promutagenic adduct in this system. None of the measured DNA adducts correlate significantly with mutabilities of ApG, ApT, CpC, TpA or TpG, although these were mutable dinucleotides (14) .
Role of endogenous DNA adducts in spontaneous mutation formation The spectrum and frequency of spontaneous mutations in any gene result from the misreplication or misrepair of endogenous DNA adducts, and are dependent upon the fidelity of the polymerases and repair enzymes involved as well as the extent and types of DNA adducts present. Thus, the spectra of spontaneous mutations recovered from Escherichia coli and from Mus musculus for the identical lacI gene are quite different, with four base deletions and insertions being the most frequently observed mutation in bacteria, and base substitutions dominating the mammalian mutation spectrum (57) (58) (59) .
One prominent feature of the spontaneous mutation spectrum in the lacI gene in vivo is the high frequency of GC to AT transitions, many of which occur at CpG dinucleotides. These have been attributed to the spontaneous deamination of 5-methylcytosine to yield thymine (60) . Cytosines in CpG dinucleotides are frequently methylated in vivo by mammalian methyltransferases, and the lacI gene in Big Blue mice has been shown to be highly methylated (61) . However, studies by Skopek et al. (62, 63) have cast doubt on this underlying mechanism for production of GC to AT transitions. A lacI gene analogue was constructed which had an identical amino acid sequence to the original lacI gene, but which removed 86% of the CpG dinucleotides (the target for in vivo cytosine methylation) from the DNA sequence. However, the spontaneous mutant frequency for transgenic mice with this gene analogue was not significantly different than that Bolded values are significantly different than corresponding control values (P , 0.05).
Conazoles modulate endogenous DNA adducts observed in the original lacI transgenics, and a high proportion of the mutations observed were still GC to AT transitions, leading the authors to conclude that a process other than deamination of 5-methylcytosine is probably generating these mutations.
A variety of different types of endogenous DNA adducts are produced as a consequence of cellular metabolism, including base damage induced by various reactive oxygen species, lipid peroxidation byproducts, including malondialdehyde, acrolein and 4-hydroxy-2-alkenals, and other reactive endogenous electrophiles (21, 26, (64) (65) (66) (67) (68) (69) (70) (71) . Abasic sites are also produced, either as a consequence of glycosyl bond labilisation induced by specific base damage or by the action of repair glycosylases. The involvement of such endogenous damage in contributing to spontaneous mutation spectra has been clearly demonstrated in studies in which production of reactive oxygen species been inhibited by administration of antioxidants (22) (23) (24) (25) 28, 72) , or by overproduction of superoxide dismutase (73) , leading to a reduction in spontaneous mutant frequency in each case. Thus, the production of the mutations comprising either spontaneous or induced mutation spectra are the same, i.e. the operation of replication and repair enzymes on damaged DNA templates. The only difference is the sources, types and extents of DNA damage.
Role of increased endogenous DNA adducts in conazole tumorigenic mode of action Tumorigenic conazoles have a complex mode of action in mouse liver, involving binding to and activating nuclear receptors CAR and PXR, inducing a variety of cytochromes P450, causing oxidative stress, disregulating cholesterol biosynthesis and metabolism, modulating retinoic acid metabolism, inducing hyperplasia and hypertrophy and inducing alterations in expression of specific genes and microRNAs (17, 29, 74, 75) . Propiconazole and triadimefon both induce expression of multiple cytochromes P450, including Cyp1a2, Cyp2b20, Cyp3a11, Cyp26a1, Cyp2c37 and Cyp2c55 (17). Further, propiconazole has recently been shown to increase reactive oxygen species in both mouse liver tissues in vivo and in AML12 immortalised mouse hepatocytes in vitro (20) . Given the pleiotropic effects induced by conazoles, the potential contribution of increased endogenous DNA adducts and increased in vivo mutant frequency to the carcinogenic mode of action must be considered in context.
It is clear that conazoles are not classical genotoxins. They are not themselves metabolised to DNA binding reactive species, and thus do not operate via a mutagenic mode of action as defined in Environmental Protection Agency guidelines for carcinogen risk assessment (76, 77) . Nonetheless, there are precedents for non-DNA-reactive carcinogens to be in vivo mutagens. Several 'nongenotoxic' chemicals have previously been reported to be weak in vivo mutagens in transgenic mouse assays, including phenobarbital, oxazepam, Wyeth 14,643 and dicyclanil (4) (5) (6) 78, 79) . These chemicals have also been reported to increase DNA damage in vivo (4, 6) .
The increase in mutant frequency upon treatment with propiconazole and triadimefon was observed only after 4 days of administration. One possible contributor to this rapid increase in mutant frequency upon exposure to tumorigenic conazoles is the early burst of increased cell proliferation and concomitant oxidative stress previously reported in mouse liver upon exposure to these conazoles by Allen et al. (29) , who found that cell proliferation in mouse liver was increased 5.5-, 2.4-and 5.0-fold relative to controls for propiconazole, triadimefon, and myclobutanil, respectively, after 4 days using the same doses and routes of administration as employed in our studies. While it has been convincingly demonstrated that increased cell proliferation alone is not adequate to elevate in vivo mutant frequencies in transgenic rodent mutation assays (80) (81) (82) , it is clear that either cell proliferation or error-prone DNA repair must take place to allow for fixation of DNA adducts into mutations. Thus, current recommendations for transgenic rodent mutation assay design typically allow for sampling up to 28 days after completion of test substance administration to allow for maximal detection of mutation induction in slowly proliferating tissues (83) . In the case of the conazoles, we hypothesise that exposure induces a rapid burst of proliferation in the liver that is adequate to allow for enough mutation fixation to permit detection after 4 days of exposure. However, the tumorigenic conazoles must also induce an increase in promutagenic DNA adducts to yield an increase in mutant frequency. Myclobutanil, like triadimefon and propiconazole, has previously been shown to induce an initial burst of proliferation in mouse liver (29), but does not induce an increase in endogenous DNA adducts, and does not induce any increase in mutations in liver DNA or liver tumours. This is highly analogous to the situation with dicyclanil, which induces significant increases in 8-oxo-dG and hypertrophy in both male and female mice, but induced increased cell proliferation only in females. Gpt mutant frequencies were significantly elevated in the treated females, but not in the males. These results were consistent with the observation that dicyclanil is a hepatotumorigen in female but not male mice (6, 84) .
In conclusion, the observations that the nongenotoxic mouse hepatotumorigens propiconazole and triadimefon rapidly induce significant elevations in specific subsets of endogenous DNA adducts resulting from increased oxidative stress, concomitant with an increase in cell proliferation, provide a plausible explanation for the previously reported in vivo mutagenicity of these chemicals. These results also demonstrate the potential utility of assessing endogenous DNA adduct levels and cellular proliferation rates as adjuncts to transgenic rodent mutation assays to aid in understanding the mechanistic basis for in vivo mutagenicity of nongenotoxic carcinogens.
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